Related references
Note: Only part of the references are listed.Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
Nigel S. Key et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial
Robert D. McBane et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Medication Adherence, Health Care Utilization, and Spending Among Privately Insured Adults With Chronic Conditions in the United States, 2010-2016
Catherine W. Gillespie et al.
AMERICAN JOURNAL OF MEDICINE (2020)
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis
Ang Li et al.
THROMBOSIS RESEARCH (2019)
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Gary E. Raskob et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Cancer-Associated Venous Thromboembolic Disease, Version 2.2018 Featured Updates to the NCCN Guidelines
Michael B. Streiff et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study
Margaret C. Fang et al.
MEDICAL CARE (2017)
Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report
Clive Kearon et al.
CHEST (2016)
Identification of smoking using Medicare data a validation study of claims-based algorithms
Rishi J. Desai et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2016)
Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism
A. Young et al.
THROMBOSIS RESEARCH (2016)
Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer A Randomized Clinical Trial
Agnes Y. Y. Lee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Household Net Worth, Racial Disparities, and Hormonal Therapy Adherence Among Women With Early-Stage Breast Cancer
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Venous thrombosis and cancer: from mouse models to clinical trials
Y. Hisada et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Improving accuracy of International Classification of Diseases codes for venous thromboembolism in administrative data
Kristen M. Sanfilippo et al.
THROMBOSIS RESEARCH (2015)
Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States
Alok A. Khorana et al.
CANCER (2013)
A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data
Leonardo Tamariz et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
Peter C. Austin
MULTIVARIATE BEHAVIORAL RESEARCH (2011)
Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States
Richard H. White et al.
THROMBOSIS RESEARCH (2010)
Medication compliance and persistence: Terminology and definitions
Joyce A. Cramer et al.
VALUE IN HEALTH (2008)
Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer
Russell D. Hull et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Secondary prevention of venous thromboembolic events in patients with active cancer: Enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period
Steven R. Deitcher et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2006)
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
HD Quan et al.
MEDICAL CARE (2005)
Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the women's health initiative
SR Heckbert et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
AYY Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
